Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
5,979
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model

Surya Murtya Department of Bioengineering, Stanford University School of Medicine, Stanford, CA;b Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Samuel T. Hailec Department of Immunology, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Corinne Beinatb Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Amin Aalipoura Department of Bioengineering, Stanford University School of Medicine, Stanford, CA;b Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA;d Medical Scientist Training Program, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Israt S. Alamb Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Tara Murtyd Medical Scientist Training Program, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Travis M. Shafferb Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Chirag B. Patelb Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA;e Division of Neuro-Oncology, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Edward E. Gravesf Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA;g Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Crystal L. Mackallg Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA;h Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USAView further author information
&
Sanjiv S. Gambhira Department of Bioengineering, Stanford University School of Medicine, Stanford, CA;b Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA, USA;g Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA;i Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA;j Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA, USACorrespondence[email protected]
View further author information
 show all
Article: 1757360 | Received 13 Sep 2019, Accepted 25 Dec 2019, Published online: 13 May 2020

References

  • Johnson DR, O’Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012;107(2):359–10. doi:10.1007/s11060-011-0749-4.
  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med [Internet]. 2005;352(10):987–996. http://login.proxy.library.vanderbilt.edu/login?url=http://search.proquest.com/docview/223934687?accountid=14816%5Cnhttp://sfx.library.vanderbilt.edu/vu?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&genre=article&sid=ProQ:ProQ:healthcomplet.
  • Gallego O. Nonsurgical treatment of recurrent glioblastoma. Curr Oncol [Internet]. 2015;22(4):e273–81. doi:10.3747/co.22.2436.
  • Lin Y, Okada H. Cellular immunotherapy for malignant gliomas. Expert Opin Biol Ther [Internet]. 2016;2598(August):1–11. doi:10.1080/14712598.2016.1214266.
  • Galluzzi L, Vacchelli E, Bravo-San Pedro J-M, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado J-P, Agostinis P, et al. Classification of current anticancer immunotherapies. Oncotarget. 2014;5(24). doi:10.18632/oncotarget.2998.
  • Ying Z, Huang XF, Xiang X, Liu Y, Kang X, Song Y, Guo X, Liu H, Ding N, Zhang T, et al. A safe and potent anti-CD19 CAR T cell therapy. Nat Med [Internet]. 2019;25(86):947–953. http://www.nature.com/articles/s41591-019-0421-7.
  • O’Rourke DM, Nasrallah MP, Desai A, Melenhorst JJ, Mansfield K, Morrissette JJD, Martinez-Lage M, Brem S, Maloney E, Shen A, et al. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci Transl Med. 2017;9(July):eaaa0984. doi:10.1126/scitranslmed.aaa0984.
  • Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR, Blanchard MS, Kilpatrick J, Simpson J, et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med [Internet]. 2016;375(26):2561–2569. http://www.ncbi.nlm.nih.gov/pubmed/28029927%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5390684.
  • Sampson JH, Choi BD, Sanchez-Perez L, Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap EA, Norberg PK, et al. EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clin Cancer Res. 2014;20(4):972–984. doi:10.1158/1078-0432.CCR-13-0709.
  • Johnson LA, Scholler J, Ohkuri T, Kosaka A, Patel PR, McGettigan SE, Nace AK, Dentchev T, Thekkat P, Loew A, et al. Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma. Sci Transl Med [Internet]. 2015;7(275):275ra22–275ra22. doi:10.1126/scitranslmed.aaa4963.
  • Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KKH, et al. Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2016;126(8):3036–3052. doi:10.1172/JCI83416.
  • Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, Williams J, Habte F, Wagner JR, Forman S, et al. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med [Internet]. 2017;9(373). http://stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aag2196%5Cnpapers3://publication/doi/10.1126/scitranslmed.aag2196.
  • Tavaré R, McCracken MN, Zettlitz KA, Knowles SM, Salazar FB, Olafsen T, Witte ON, Wu AM. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo. Proc Natl Acad Sci U S A [Internet]. 2014;111(3):1108–1113. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3903195&tool=pmcentrez&rendertype=abstract.
  • Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med [Internet]. 2007;204(2):345–356. http://www.ncbi.nlm.nih.gov/pubmed/17261634%5Cnhttp://jem.rupress.org/content/204/2/345.full.pdf%5Cn%3CGotoISI%3E://000244504100014%5Cnhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118741/pdf/jem2040345.pdf.
  • Lodygin D, Odoardi F, Schläger C, Körner H, Kitz A, Nosov M, van den Brandt J, Reichardt HM, Haberl M, Flügel A, et al. A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity. Nat Med [Internet]. 2013;19(6):784–790. http://www.ncbi.nlm.nih.gov/pubmed/23624600.
  • Ricard C, Debarbieux FC. Six-color intravital two-photon imaging of brain tumors and their dynamic microenvironment. Front Cell Neurosci [Internet]. 2014;8(February):57. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3932518&tool=pmcentrez&rendertype=abstract.
  • Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WEF, Goldbrunner R, Herms J, Winkler F. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med [Internet]. 2010;16(1):116–122. http://www.ncbi.nlm.nih.gov/pubmed/20023634.
  • Bayerl SH, Niesner R, Cseresnyes Z, Radbruch H, Pohlan J, Brandenburg S, Czabanka MA, Vajkoczy P. Time lapse In Vivo microscopy reveals distinct dynamics of microglia-tumor environment interactions — a new role for the tumor perivascular space as highway for trafficking microglia. Glia. 2016.
  • Spary LK, Al-Taei S, Salimu J, Cook AD, Ager A, Watson HA, Clayton A, Staffurth J, Mason MD, Tabi Z. Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation; 2019.
  • Dovedi SJ, Cheadle EJ, Popple AL, Poon E, Morrow M, Stewart R, Yusko EC, Sanders CM, Vignali M, Emerson RO, et al. Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade. J Immunol. 2017;23(18):5514–5527.
  • Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006;203(5):1259–1271. doi:10.1084/jem.20052494.
  • Schulz G, Cheresh DA, Varki NM, Yu A, Staffileno LK, Reisfeld RA. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma. Cancer Res. 1984;44:5914–5920.
  • Dobrenkov K, Cheung NV, Ostrovnaya I, Gu J, Cheung IY. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults. Pediatr Blood Cancer. 2016;63(10):1780–1785. doi:10.1002/pbc.26097.
  • Mount CW, Majzner RG, Sundaresh S, Arnold EP, Kadapakkam M, Haile S,  Labanieh L, Hulleman E, Woo PJ, Rietberg SP, et al. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas. Nat Med [Internet]. 2018;24(May). http://www.nature.com/articles/s41591-018-0006-x.
  • Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, Smith JP, Walker AJ, Kohler ME, Venkateshwara VR, et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med [Internet]. 2015;21(6):581–590. http://www.ncbi.nlm.nih.gov/pubmed/25939063.
  • Haraguchi M, Yamashiro S, Furukawa K, Furukawa K, Takamiya K, Lloyd KO, Shiku H, Furukawa K. Isolation of GD3 synthase gene by expression cloning of GM3 a-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci U S A. 1994;91(October):10455–10459. doi:10.1073/pnas.91.22.10455.
  • Ray P, Gambhir SS. Noninvasive imaging of molecular events with bioluminescent reporter genes in living subjects. Methods Mol Bio. 2007.
  • Chow KK, Naik S, Kakarla S, Brawley VS, Shaffer DR, Yi Z, Rainusso N, Wu M-F, Liu H, Kew Y, et al. T cells redirected to EphA2 for the immunotherapy of glioblastoma. Mol Ther [Internet]. 2013;21(3):629–637. http://linkinghub.elsevier.com/retrieve/pii/S1525001616306323.
  • Kong S, Sengupta S, Tyler B, Bais AJ, Ma Q, Doucette S, Zhou J, Sahin A, Carter BS, Brem H, et al. Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res. 2012;18(21):5949–5960. doi:10.1158/1078-0432.CCR-12-0319.
  • Weiss T, Weller M, Guckenberger M, Sentman CL, Roth P. NKG2D-based CAR T cells and radiotherapy exert synergistic efficacy in glioblastoma. Cancer Res. 2018;78(4):1031–1043. doi:10.1158/0008-5472.CAN-17-1788.
  • Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE, Gottschalk S. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin Cancer Res. 2010;16(2):474–485. doi:10.1158/1078-0432.CCR-09-1322.
  • Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Specific recognition and killing of glioblastoma multiforme by 13-zetakine redirected cytolytic T cells. Cancer Res. 2004;64(24):9160–9166. doi:10.1158/0008-5472.CAN-04-0454.
  • Liu K, Liu X, Peng Z, Sun H, Zhang M, Zhang J, Liu S, Hao L, Lu G, Zheng K, et al. Retargeted human avidin-CAR T cells for adoptive immunotherapy of EGFRvIII expressing gliomas and their evaluation via optical imaging. Oncotarget [Internet]. 2015;6(27):23735–23747. http://www.ncbi.nlm.nih.gov/pubmed/26124178.
  • Richman SA, Nunez-Cruz S, Moghimi B, Li LZ, Gershenson ZT, Mourelatos Z, Barrett DM, Grupp SA, Milone MC. High-affinity GD2-specific CAR T cells induce fatal encephalitis in a preclinical neuroblastoma model. Cancer Immunol Res [Internet]. 2017;(Mcm):canimm.0211.2017. doi:10.1158/2326-6066.CIR-17-0211.
  • Flores C, Pham C, Snyder D, Yang S, Sanchez-Perez L, Sayour E, Cui X, Kemeny H, Friedman H, Bigner DD, et al. Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas. Oncoimmunology [Internet]. 2015;4(3):e994374. doi:10.4161/2162402X.2014.994374.
  • Wang LX, Shu S, Plautz GE. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells. Cancer Res. 2005;65(20):9547–9554. doi:10.1158/0008-5472.CAN-05-1175.
  • Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science (80-). 2015;348(6230):6230. doi:10.1126/science.aaa6204.
  • Salmon H, Franciszkiewicz K, Damotte D, Validire P, Trautmann A, Mami-chouaib F, Mami-Chouaib F, Donnadieu E. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012;122(3):899–910. doi:10.1172/JCI45817.
  • Murty S, Gilliland T, Qiao P, Tabtieng T, Higbee E, Al Zaki A, Puré E, Tsourkas A. Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model. Part Part Syst Charact [Internet]. 2014 Nov 10 [cited 2014 Nov 20];n/a-n/a. doi:10.1002/ppsc.201400169.
  • Krauze A, Attia A, Braunstein S, Chan M, Combs S, Fietkau R. Expert consensus on re-irradiation for recurrent glioma. 2017;1–10.
  • Amelio D, Amichetti MA. Radiation therapy for the treatment of recurrent glioblastoma: an overview. Cancers (Basel). 2012;4(1):257–280. doi:10.3390/cancers4010257.
  • Kazmi F, Yang Y, Yiat S, Leong H, Yao W, Balamurugan K. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis. J Neurooncol [Internet]. 2019;142(1):79–90. doi:10.1007/s11060-018-03064-0.
  • Shah JL, Li G, Shaffer JL, Azoulay MI, Gibbs IC, Nagpal S, Soltys SG. Stereotactic radiosurgery and hypofractionated. Neurosurgery. 2018;82(1):24–34. doi:10.1093/neuros/nyx115.
  • Menichetti L, Petroni D, Panetta D, Burchielli S, Bortolussi S, Matteucci M, Pascali G, Del Turco S, Del Guerra A, Altieri S, et al. A micro-PET/CT approach using O-(2-[18F]fluoroethyl)-l-tyrosine in an experimental animal model of F98 glioma for BNCT. Appl Radiat Isot [Internet]. 2011;69(12):1717–1720. doi:10.1016/j.apradiso.2011.02.037.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.